Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease

QR Code

Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease

Current evidence on benefits of night-time blood pressure (BP) lowering drug treatment on cardiovascular disease (CVD) prevention attributable to the Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (MAPEC) trial and Bedtime hypertension tr...

Full description

Bibliographic Details
Main Authors:	Ho, Chau Le Bao, Reid, Christopher
Format:	Journal Article
Published:	2022
Online Access:	http://purl.org/au-research/grants/nhmrc/1111170 http://hdl.handle.net/20.500.11937/93104

Similar Items

The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)

Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials
by: Czernichow, S., et al.
Published: (2011)

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
by: Lonn, E., et al.
Published: (2016)

Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)

Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
by: Lonn, Eva M., et al.
Published: (2016)

POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017)

Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)

NIGHT-TIME AMBULATORY BLOOD PRESSURE IS THE BEST PRETREATMENT BLOOD PRESSURE PREDICTOR OF 11-YEAR MORTALITY IN OLDER HYPERTENSIVES
by: Wing, L., et al.
Published: (2017)

Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
by: Wing, L., et al.
Published: (2018)

Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020)

Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
by: Ho, C., et al.
Published: (2017)

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.
by: Blood Pressure Lowering Treatment Trialists' Collaboration, et al.
Published: (2015)

Pharmacogenetics in cardiovascular disorders: An update on the principal drugs
by: Predazzi, I., et al.
Published: (2013)

Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)

Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
by: Dhaliwal, Satvinder, et al.
Published: (2017)

SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)

Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)

Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial
by: Joseph, P., et al.
Published: (2018)

Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: The perindopril protection against recurrent stroke study trial
by: Czernichow, S., et al.
Published: (2010)

Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis
by: De Courten, B., et al.
Published: (2008)

Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)

Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)

Nitrate-rich vegetables do not lower blood pressure in individuals with mildly elevated blood pressure: A 4-wk randomized controlled crossover trial
by: Blekkenhorst, L., et al.
Published: (2018)

Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016
by: Si, Si, et al.
Published: (2018)

Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)
by: Sharman, J., et al.
Published: (2017)

Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Bennett, A., et al.
Published: (2017)

Blood pressure lowering mechanisms of Kadukmy™ in essential hypertension
by: Mohd Zainudin, Maizura, et al.
Published: (2019)

Novel blood pressure-lowering effect of spathulenol in rats
by: Raslan Ain-Fatin,, et al.
Published: (2024)

Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis
by: Chan, C., et al.
Published: (2009)

Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: main results from the pilot ‘Prevention of decline in cognition after stroke trial’ (PODCAST) randomised controlled trial
by: Bath, Philip M.W., et al.
Published: (2017)

Effects of vegetarian diets on blood pressure lowering: a systematic review with meta‐analysis and trial sequential analysis
by: Lee, Kai Wei, et al.
Published: (2020)

Effects of qigong on systolic and diastolic blood pressure lowering: a systematic review with meta-analysis and trial sequential analysis
by: Siew, Mooi Ching, et al.
Published: (2021)

Blood pressure variables and cardiovascular risk: New findings from advance
by: Kengne, A., et al.
Published: (2009)

Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort
by: Nelson, M., et al.
Published: (2009)

A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings
by: Head, G., et al.
Published: (2010)

Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the asia-pacific region
by: Nakamura, K., et al.
Published: (2008)

Lipid and blood pressure lowering effects of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2023)

Lipid and blood pressure lowering potential of Mikania micrantha through enzymatic inhibition
by: Shafie, Nurul Husna, et al.
Published: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r2epso5ohjcl0oqpmbtfo7ufrh